Surging oil prices and a weak dollar prompted a spate of profit-taking today, pushing stocks slightly lower in light holiday-week trading.

IN a major development, Waterford -based Genzyme Corp. of the United States announced FDA approval for the production of Renagel, a further step toward consolidating the group’s Irish manufacturing presence, the company said.